genetronlogo.JPG
Genetron Health to Announce First Quarter 2021 Financial Results and Host Investor Call on May 24, 2021
May 03, 2021 17:00 ET | Genetron Holdings Limited
BEIJING, May 03, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
genetronlogo.JPG
Genetron Health to Present at Upcoming Investor Conferences
April 22, 2021 18:25 ET | Genetron Holdings Limited
BEIJING, April 22, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
genetronlogo.JPG
Genetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit
April 01, 2021 18:00 ET | Genetron Holdings Limited
BEIJING, April 01, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
genetronlogo.JPG
Genetron Health to Present at CNBC East Tech West Conference
November 12, 2020 05:30 ET | Genetron Holdings Limited
BEIJING, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in...
genetronlogo.JPG
Genetron Health Reports Third Quarter 2020 Unaudited Financial Results and Provides Business Update
November 09, 2020 06:30 ET | Genetron Holdings Limited
BEIJING, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in...
genetronlogo.JPG
Genetron Health to Present at Six Upcoming Investor and Industry Conferences
October 29, 2020 08:00 ET | Genetron Holdings Limited
BEIJING, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...
genetronlogo.JPG
Genetron Health to Announce Third Quarter Unaudited Financial Results and Host Investor Call on November 9, 2020
October 26, 2020 08:00 ET | Genetron Holdings Limited
BEIJING, China, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes...
WeChat Image_20200917115104.png
Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer
October 22, 2020 06:00 ET | Genetron Holdings Limited
BEIJING, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering...
WeChat Image_20200917115104.png
Genetron Health Receives U.S. FDA Breakthrough Device Designation for its Blood-based NGS Test for Early Detection of Hepatocellular Carcinoma
September 30, 2020 08:11 ET | Genetron Holdings Limited
BEIJING and GAITHERSBURG, Md., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China...
WeChat Image_20200917115104.png
Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib
September 25, 2020 06:00 ET | Genetron Holdings Limited
BEIJING and SUZHOU, China, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in...